1. Home
  2. ATNM vs MAXN Comparison

ATNM vs MAXN Comparison

Compare ATNM & MAXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.58

Market Cap

50.2M

Sector

Health Care

ML Signal

HOLD

Logo Maxeon Solar Technologies Ltd.

MAXN

Maxeon Solar Technologies Ltd.

HOLD

Current Price

$3.40

Market Cap

45.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATNM
MAXN
Founded
2000
2019
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
50.2M
45.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ATNM
MAXN
Price
$1.58
$3.40
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
224.5K
72.1K
Earning Date
11-14-2025
03-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$90,000.00
$176,414,000.00
Revenue This Year
N/A
$100.37
Revenue Next Year
$42,943.57
$24.61
P/E Ratio
N/A
N/A
Revenue Growth
11.11
N/A
52 Week Low
$1.03
$2.49
52 Week High
$2.41
$9.05

Technical Indicators

Market Signals
Indicator
ATNM
MAXN
Relative Strength Index (RSI) 65.07 54.63
Support Level $1.37 $2.92
Resistance Level $1.54 $3.73
Average True Range (ATR) 0.08 0.22
MACD 0.02 0.08
Stochastic Oscillator 72.95 57.61

Price Performance

Historical Comparison
ATNM
MAXN

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

About MAXN Maxeon Solar Technologies Ltd.

Maxeon Solar Technologies Ltd is engaged in the manufacturing and marketing of premium solar technology. It owns and operates solar cell and panel manufacturing facilities located in Malaysia, Mexico, and the Philippines. The company's primary products are the Maxeon line of interdigitated back contact (IBC) solar cells and panels, and the Performance line (formerly, P-Series) of shingled solar cells and panels. the Maxeon line of solar panels are the highest-efficiency solar panels on the market with an aesthetically pleasing design, and the Performance line of solar panels offers a high-value and cost-effective solution. It is targeted at residential and small-scale commercial customers across the globe. The company derives its revenue from the United States, Italy, and Rest of world.

Share on Social Networks: